Estuary research mission. Benefits of cycling. Promoting the electric car. Pink Viagra.

The scholarly work of Concordia faculty and researchers informs and improves society on many issues that affect our daily lives. Visit the Research section to read news stories involving research at Concordia, or read the most recent items here:   

• Canadian Light Source reports on the work of Concordia researchers during a recent environmental science mission in the St-Lawrence estuary on board the research vessel, Coriolis II. The team included Yves Gélinas, professor and Concordia University Research Chair in Environmental Chemistry, and doctoral candidate Andrew Barber, both in the Department of Chemistry and Biochemistry in the Faculty of Arts and Science. Gélinas is quoted and he and Barber are pictured with lab members Kathryn Balind, Aleshia Kormendi, and Anic Imfeld.
• Business News Daily, UK Press From, MSN Health and Times Indonesia (in Indonesian) pick up news of a newstudy from Concordia that looks at the benefits of cycling. Researchers Stéphane Brutus, professor of management and RBC Professor of Motivation and Employee Performance, associate professor of management Alexandra Panaccio and JMSB research assistant Roshan Javadian (MSc 14,) noted that employees who ride their bike to work report lower stress levels. The study was published in the International Journal of Workplace Health Management.
• Global Specs Insight joins coverage of new research led by Ian Irvine, professor of economics in the Faculty of Arts and Science, that examines government incentives to promote the sale of electric vehicles. In the study published in Canadian Public Policy, Irvine concludes that electric vehicle subsidies may work at cross purposes with existing fuel-efficiency subsidies for conventional vehicles.
• The Vancouver Sun reprises an article from The National Post about a plan by Valeant Pharmaceuticals to re-launch Addyi, dubbed the "pink Viagra" for women. It references the early work of Jim Pfaus, professor of psychology in the Faculty of Arts and Science, on flibanserin (Addyi). Pfaus is quoted.

 More Researchers in the news